1425 results
Thumbnail

D3.489 - Anaphylaxis Diagnosis and Treatment from the Perspective of Primary Care Physicians

Thumbnail

D3.49 - Associations between the prevalence of sensitization of pets and symptoms of allergic rhinitis (AR) in children

Thumbnail

D3.490 - AllergyIQ: An Interactive Virtual Educational Platform in Allergy and Immunology

Thumbnail

D3.491 - Satisfaction with Sebetralstat as On-Demand Treatment of Hereditary Angioedema Attacks in KONFIDENT-S

Thumbnail

D2.273 - The frequency of metal sensitisation in patients who are about to undergo joint replacement

Thumbnail

D2.288 - Real- World Safety of Supervised Feeds: Evidence from Outpatient Clinic and Dayward Settings

Thumbnail

D3.196 - Safety of subcutaneous immunotherapy with purified native protein Cup a 1, a major allergen of Cupressus arizonica: 6-year real-world data

Thumbnail

D3.206 - Pollen-Food Allergy Syndrome (PFAS): A New Paradigm in Allergy Practice – Results of a Survey Among Allergists

Thumbnail

D3.227 - The effect of subcutaneous allergen immunotherapy after one year on the quality of life of children with perennial allergic rhinitis and rhinoconjunctivitis

Thumbnail

D3.248 - Prospective Evaluation Of The Efficacy Of Janus Kinase Inhibitor Therapy In Children With Alopecia Areata And Atopic Dermatitis

Thumbnail

D3.250 - Changes in eating behavior in children with psoriasis during biological therapy depending on epicardial adipose tissue thickness

Thumbnail

100199 - Availability of skin-friendly personal protective equipment for healthcare workers with atopic dermatitis: a hospital-wide audit

Thumbnail

D1.105 - Real-Life Evidence of Type 2 Immunomodulation with Benralizumab: From Steroid-Dependent to Controlled Asthma

Thumbnail

D1.106 - Dupilumab-Induced Systemic Eosinophilic Immune Activation Mimicking an EGPA-Like Prodrome: A Case Report

Thumbnail

D1.108 - Optimization of phenotyping in severe T2-bronchial asthma

Thumbnail

D1.109 - Biologics selection algorithm for severe T2-bronchial asthma targeted therapy

Thumbnail

D1.110 - Long Term Mepolizumab in Type-2 CRSwNP: Marked Polyp Reduction, Symptom Relief, and Airway Benefits in Real World Comorbid Patients

Thumbnail

D1.113 - Effect of mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a real-world retrospective observational study

Thumbnail

D1.115 - Real World Assessment of Uncontrolled Severe Asthma in Canada - A Multi-Site Qualitative Survey of Type 2 Inflammatory Biomarkers and Clinical Outcomes

Thumbnail

D1.121 - Association of Serum Club Cell Secretory Protein 16 (CC16) with House Dust Mite Sensitization in Children with Asthma